Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPACC: L-Carnitine for Anthracycline-Induced Cardiotoxicity in Breast Cancer
NCT00247975Phase 3Terminated
- Sponsor
- University of Ottawa Heart Institute
- Start
- Mar 2006
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocarnitine in anthracycline-induced cardiotoxicity, sponsored by University of Ottawa Heart Institute. Started Mar 2006; status: terminated.
02
Drugs
levocarnitine
03
Conditions
anthracycline-induced cardiotoxicity
Beyond the preview
Go deeper on NCT00247975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247975.